Recurrent abdominal liposarcoma: Analysis of 19 cases and prognostic factors

被引:1
|
作者
Wei Lu [1 ]
James Lau [2 ]
Mei-Dong Xu [1 ]
Yong Zhang [1 ]
Ying Jiang [1 ]
Han-Xing Tong [1 ]
Juan Zhu [1 ]
Wei-Qi Lu [1 ]
Xin-Yu Qin [1 ]
机构
[1] General Surgery Department, Zhongshan Hospital, Fudan University
[2] Department of Surgery, Stanford School of Medicine
关键词
Overall survival; Recurrent abdominal lipo-sarcoma; Relapse-free interval;
D O I
暂无
中图分类号
R730.5 [肿瘤治疗学];
学科分类号
100214 ;
摘要
AIM: To evaluate the clinical outcome of re-operation for recurrent abdominal liposarcoma following multidis-ciplinary team cooperation. METHODS: Nineteen consecutive patients who had re-current abdominal liposarcoma underwent re-operation by the retroperitoneal sarcoma team at our institution from May 2009 to January 2012. Patient demographic and clinical data were reviewed retrospectively. Multidisciplinary team discussions were held prior to treatment, and re-operation was deemed the best treatment. The categories of the extent of resection were as follows: gross total resection (GTR), palliative resection and partial resection. Surgical techniques were divided into discrete lesion resection and combined contiguous multivisceral resection (CMR). Tumor size was determined as the largest diameter of the specimen. Patients were followed up at approximately 3-monthly intervals. For survival analysis, a univariate analysis was performed using the Kaplan-Meier method, and a multivariate analysis was performed using the Cox pro-portional hazards model. RESULTS: Nineteen patients with recurrent abdominal liposarcoma (RAL) underwent 32 re-operations at our institute. A total of 51 operations were reviewed with a total follow-up time ranging from 4 to 120 (47.4 ± 34.2) mo. The GTR rate in the CMR group was higher than that in the non-CMR group (P = 0.034). CMR was positively correlated with intra-operative bleeding (correlation coefficient = 0.514, P = 0.010). Six cases with severe postoperative complications were recorded. Patients with tumor sizes greater than 20 cm carried a significant risk of profuse intra-operative bleeding (P = 0.009). The ratio of a highly malignant subtype (de-differentiated or pleomorphic) in recurrent cases was higher compared to primary cases (P = 0.027). Both single-factor survival using the Kaplan-Meier model and multivariate analysis using the Cox proportional hazards model showed that overall survival was corre-lated with resection extent and pathological subtype (P < 0.001 and P = 0.02), however, relapse-free interval (RFI) was only correlated with resection extent (P = 0.002). CONCLUSION: Close follow-up should be conducted in patients with RAL. Early re-operation for relapse is preferred and gross resection most likely prolongs the RFI.
引用
收藏
页码:4045 / 4052
页数:8
相关论文
共 50 条
  • [11] Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases
    Ming Chen
    Jun Yang
    Lei Zhu
    Cao Zhou
    Heng Zhao
    Journal of Cardiothoracic Surgery, 9
  • [12] Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases
    Chen, Ming
    Yang, Jun
    Zhu, Lei
    Zhou, Cao
    Zhao, Heng
    JOURNAL OF CARDIOTHORACIC SURGERY, 2014, 9
  • [13] Giant abdominal recurrent liposarcoma with multiple histological types
    Alvarez-Llano, L.
    Martin-Gil, J.
    Garcia-Marin, A.
    Sanchez-Rodriguez, T.
    Martinez-Izquierdo, M. A.
    Bernardos-Garcia, L. E.
    Perez-Diaz, M. D.
    Turegano-Fuentes, F.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2010, 102 (03) : 202 - 203
  • [14] Prognostic factors of metastatic myxoid liposarcoma
    Yusuke Shinoda
    Eisuke Kobayashi
    Hiroshi Kobayashi
    Tomoaki Mori
    Naofumi Asano
    Robert Nakayama
    Hideo Morioka
    Shintaro Iwata
    Tsukasa Yonemoto
    Takeshi Ishii
    Tohru Hiruma
    Akira Kawai
    Hirotaka Kawano
    BMC Cancer, 20
  • [15] Prognostic factors of metastatic myxoid liposarcoma
    Shinoda, Yusuke
    Kobayashi, Eisuke
    Kobayashi, Hiroshi
    Mori, Tomoaki
    Asano, Naofumi
    Nakayama, Robert
    Morioka, Hideo
    Iwata, Shintaro
    Yonemoto, Tsukasa
    Ishii, Takeshi
    Hiruma, Tohru
    Kawai, Akira
    Kawano, Hirotaka
    BMC CANCER, 2020, 20 (01)
  • [16] Clinical course and prognostic factors of patients with dedifferentiated liposarcoma: a retrospective analysis
    Casier, Jelena
    Timmermans, Iris
    Laenen, Annouschka
    Hompes, Daphne
    Douchy, Thomas
    Sciot, Raf
    Christiaens, Melissa
    Wafa, Hazem
    Schoeffski, Patrick
    BMC CANCER, 2025, 25 (01)
  • [17] Verrucous Carcinoma of the Foot: A Retrospective Study of 19 Cases and Analysis of Prognostic Factors Recurrence
    Prince, Andrew D. P.
    Harms, Paul W.
    Harms, Kelly L.
    Kozlow, Jeffrey H.
    CUTIS, 2022, 109 (03): : E21 - E28
  • [18] Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up
    Lemeur, M.
    Mattei, J. -C.
    Souteyrand, P.
    Chagnaud, C.
    Curvale, G.
    Rochwerger, A.
    ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH, 2015, 101 (01) : 103 - 107
  • [19] Prognostic factors of head and neck adenoid cystic carcinoma: Quantitative morphological analysis of 19 cases
    Hashimoto, S
    Takahashi, H
    Okamoto, M
    Yao, K
    Nakayama, M
    Makoshi, T
    Iwabuchi, K
    ACTA OTO-LARYNGOLOGICA, 2002, 122 : 93 - 96
  • [20] Characteristics and prognostic factors of COVID-19 among infected cases: a nationwide Tunisian analysis
    Harizi, Chahida
    Cherif, Ines
    Najar, Nourhene
    Osman, Molka
    Mallekh, Rym
    Ben Ayed, Oumaima
    Ayedi, Yosr
    Dhaouadi, Sonia
    Hchaichi, Aicha
    Safer, Mouna
    Letaief, Hejer
    Bouaziz, Ilhem
    Derouiche, Sondes
    Gharbi, Donia
    Bouabid, Leila
    Bougatef, Souha
    Ben Salah, Hamida
    Fakhfakh, Radhouane
    Abid, Salma
    Ben Boubaker, Ilhem Boutiba
    Chahed, Mohamed Kouni
    Ben-Alaya, Nissaf Bouafif
    BMC INFECTIOUS DISEASES, 2021, 21 (01)